TrialArthritis research & therapy2024

Upadacitinib monotherapy versus methotrexate monotherapy in patients with rheumatoid arthritis: efficacy and safety through 5 years in the SELECT-EARLY randomized controlled trial.

Ronald van Vollenhoven et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.